vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and FONAR CORP (FONR). Click either name above to swap in a different company.

Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $25.5M, roughly 1.3× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs -1.8%, a 9.8% gap on every dollar of revenue. On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -3.2%). FONAR CORP produced more free cash flow last quarter ($-227.0K vs $-2.4M). Over the past eight quarters, FONAR CORP's revenue compounded faster (-0.3% CAGR vs -3.5%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

CLFD vs FONR — Head-to-Head

Bigger by revenue
CLFD
CLFD
1.3× larger
CLFD
$34.3M
$25.5M
FONR
Growing faster (revenue YoY)
FONR
FONR
+5.6% gap
FONR
2.4%
-3.2%
CLFD
Higher net margin
FONR
FONR
9.8% more per $
FONR
8.0%
-1.8%
CLFD
More free cash flow
FONR
FONR
$2.2M more FCF
FONR
$-227.0K
$-2.4M
CLFD
Faster 2-yr revenue CAGR
FONR
FONR
Annualised
FONR
-0.3%
-3.5%
CLFD

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CLFD
CLFD
FONR
FONR
Revenue
$34.3M
$25.5M
Net Profit
$-614.0K
$2.1M
Gross Margin
33.2%
Operating Margin
-5.3%
13.5%
Net Margin
-1.8%
8.0%
Revenue YoY
-3.2%
2.4%
Net Profit YoY
67.8%
4.7%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
FONR
FONR
Q4 25
$34.3M
$25.5M
Q3 25
$23.4M
$26.0M
Q2 25
$49.9M
$27.3M
Q1 25
$47.2M
$27.2M
Q4 24
$29.7M
$24.9M
Q3 24
$5.6M
$25.0M
Q2 24
$48.8M
$25.9M
Q1 24
$36.9M
$25.7M
Net Profit
CLFD
CLFD
FONR
FONR
Q4 25
$-614.0K
$2.1M
Q3 25
$-9.1M
$2.3M
Q2 25
$1.6M
$729.3K
Q1 25
$1.3M
$2.5M
Q4 24
$-1.9M
$2.0M
Q3 24
$3.1M
Q2 24
$-447.0K
$830.4K
Q1 24
$-5.9M
$1.9M
Gross Margin
CLFD
CLFD
FONR
FONR
Q4 25
33.2%
Q3 25
53.2%
Q2 25
30.5%
Q1 25
30.1%
Q4 24
29.2%
Q3 24
Q2 24
21.9%
Q1 24
7.7%
Operating Margin
CLFD
CLFD
FONR
FONR
Q4 25
-5.3%
13.5%
Q3 25
10.3%
14.1%
Q2 25
3.0%
5.3%
Q1 25
0.6%
15.2%
Q4 24
-6.9%
11.9%
Q3 24
21.0%
Q2 24
-4.7%
7.4%
Q1 24
-26.4%
16.8%
Net Margin
CLFD
CLFD
FONR
FONR
Q4 25
-1.8%
8.0%
Q3 25
-38.8%
8.7%
Q2 25
3.2%
2.7%
Q1 25
2.8%
9.2%
Q4 24
-6.4%
7.9%
Q3 24
12.6%
Q2 24
-0.9%
3.2%
Q1 24
-16.0%
7.3%
EPS (diluted)
CLFD
CLFD
FONR
FONR
Q4 25
$-0.04
Q3 25
$-0.65
Q2 25
$0.11
Q1 25
$0.09
Q4 24
$-0.13
Q3 24
Q2 24
$-0.04
Q1 24
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
FONR
FONR
Cash + ST InvestmentsLiquidity on hand
$96.4M
$121.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$249.7M
$176.9M
Total Assets
$268.1M
$217.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
FONR
FONR
Q4 25
$96.4M
$121.0K
Q3 25
$106.0M
$122.0K
Q2 25
$117.2M
$56.5M
Q1 25
$112.0M
$123.0K
Q4 24
$113.0M
$121.0K
Q3 24
$129.0M
$136.0K
Q2 24
$123.8M
$56.5M
Q1 24
$142.9M
$134.0K
Total Debt
CLFD
CLFD
FONR
FONR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$2.2M
Q2 24
$2.1M
$66.9K
Q1 24
Stockholders' Equity
CLFD
CLFD
FONR
FONR
Q4 25
$249.7M
$176.9M
Q3 25
$256.2M
$174.9M
Q2 25
$264.5M
$172.6M
Q1 25
$265.9M
$171.9M
Q4 24
$267.4M
$169.8M
Q3 24
$275.8M
$168.7M
Q2 24
$274.6M
$166.0M
Q1 24
$279.2M
$165.8M
Total Assets
CLFD
CLFD
FONR
FONR
Q4 25
$268.1M
$217.2M
Q3 25
$306.2M
$218.4M
Q2 25
$314.7M
$216.9M
Q1 25
$310.9M
$214.9M
Q4 24
$303.2M
$208.0M
Q3 24
$315.3M
$212.3M
Q2 24
$318.1M
$214.2M
Q1 24
$315.4M
$209.6M
Debt / Equity
CLFD
CLFD
FONR
FONR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
0.01×
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
FONR
FONR
Operating Cash FlowLast quarter
$-1.4M
$171.0K
Free Cash FlowOCF − Capex
$-2.4M
$-227.0K
FCF MarginFCF / Revenue
-7.1%
-0.9%
Capex IntensityCapex / Revenue
2.9%
1.6%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
FONR
FONR
Q4 25
$-1.4M
$171.0K
Q3 25
$1.7M
Q2 25
$7.9M
$4.2M
Q1 25
$3.0M
$3.1M
Q4 24
$7.2M
$2.2M
Q3 24
$22.2M
$1.7M
Q2 24
$4.0M
$4.6M
Q1 24
$-5.7M
$2.8M
Free Cash Flow
CLFD
CLFD
FONR
FONR
Q4 25
$-2.4M
$-227.0K
Q3 25
$-177.0K
Q2 25
$7.5M
$3.6M
Q1 25
$654.0K
$2.6M
Q4 24
$5.1M
$1.5M
Q3 24
$18.2M
$-148.0K
Q2 24
$2.8M
$4.2M
Q1 24
$-7.7M
$2.6M
FCF Margin
CLFD
CLFD
FONR
FONR
Q4 25
-7.1%
-0.9%
Q3 25
-0.7%
Q2 25
15.1%
13.1%
Q1 25
1.4%
9.4%
Q4 24
17.1%
6.0%
Q3 24
323.0%
-0.6%
Q2 24
5.8%
16.1%
Q1 24
-20.8%
10.2%
Capex Intensity
CLFD
CLFD
FONR
FONR
Q4 25
2.9%
1.6%
Q3 25
2.0%
7.2%
Q2 25
0.8%
2.4%
Q1 25
5.1%
2.2%
Q4 24
7.0%
3.0%
Q3 24
71.4%
7.2%
Q2 24
2.5%
1.6%
Q1 24
5.3%
0.7%
Cash Conversion
CLFD
CLFD
FONR
FONR
Q4 25
0.08×
Q3 25
0.75×
Q2 25
4.93×
5.79×
Q1 25
2.30×
1.26×
Q4 24
1.14×
Q3 24
0.53×
Q2 24
5.54×
Q1 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLFD
CLFD

Segment breakdown not available.

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

Related Comparisons